Location · Baton Rouge, LA
Clinical trials in Baton Rouge, LA
65 recruiting studies have a site in Baton Rouge, and 32 of them accept healthy volunteers.
65 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersOvernight stay mentioned
Experimental Approach to Test Predictions of Body Weight Regulation Models
Pennington Biomedical Research Center
- Location
- Baton Rouge, LA
- Eligibility basics
- Ages 18–40
- RecruitingHealthy volunteers
Galleri® in the Medicare Population.
GRAIL, Inc.
- Location
- Baton Rouge, LA + 70 other US sites
- Eligibility basics
- Ages 50+
- RecruitingHealthy volunteersPhase 3
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
Caliway Biopharmaceuticals Co., Ltd.
- Location
- Baton Rouge, LA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Pfizer
- Location
- Baton Rouge, LA + 138 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteersPhase 4
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
ModernaTX, Inc.
- Location
- Baton Rouge, LA + 5 other US sites
- Eligibility basics
- Ages 6 mo+
- RecruitingHealthy volunteers
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
Aptitude Medical Systems
- Location
- Baton Rouge, LA + 2 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sanofi
- Location
- Baton Rouge, LA + 118 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- Baton Rouge, LA + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2/Phase 3
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Pelage Pharmaceuticals, Inc.
- Location
- Baton Rouge, LA + 26 other US sites
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sanofi
- Location
- Baton Rouge, LA + 126 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sanofi
- Location
- Baton Rouge, LA + 33 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 4
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Takeda
- Location
- Baton Rouge, LA + 77 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Biohaven Therapeutics Ltd.
- Location
- Baton Rouge, LA + 52 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sanofi
- Location
- Baton Rouge, LA + 36 other US sites
- Eligibility basics
- Ages 16–80
- Recruiting
NORM-HF Pivotal Study
Foundry Innovation & Research 1, Limited (FIRE1)
- Location
- Baton Rouge, LA + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
UCB Biopharma SRL
- Location
- Baton Rouge, LA + 61 other US sites
- Eligibility basics
- Ages 16+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Baton Rouge, LA + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Sanofi
- Location
- Baton Rouge, LA + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Boehringer Ingelheim
- Location
- Baton Rouge, LA + 55 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
Novartis Pharmaceuticals
- Location
- Baton Rouge, LA + 14 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Incyte Corporation
- Location
- Baton Rouge, LA + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Incyte Corporation
- Location
- Baton Rouge, LA + 15 other US sites
- Eligibility basics
- Ages 12–75
- RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Eli Lilly and Company
- Location
- Baton Rouge, LA + 68 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
GlaxoSmithKline
- Location
- Baton Rouge, LA + 50 other US sites
- Eligibility basics
- Ages 40–80